Levofloxacin Cooper

Levofloxacin, the active ingredient in Levofloxacin Cooper, is a Fluoroquinolone antibiotic presented as an intravenous solution for injection use. It treats a range of serious bacterial infections in adult patients, including pneumonia, urinary tract and skin infections. GNH USA supplies Levofloxacin Cooper as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Levofloxacin Cooper is a fluoroquinolone antibiotic indicated for several bacterial infections. - Community‑acquired bacterial pneumonia: eradicates the causative pathogens to improve respiratory function. - Complicated urinary tract infections: eliminates resistant organisms to resolve infection and prevent recurrence. - Skin and soft‑tissue infections: provides rapid bacterial clearance for faster wound healing. - Acute bacterial sinusitis: reduces sinus inflammation by targeting the infecting bacteria. - Acute exacerbations of chronic bronchitis: controls bacterial load to lessen symptom severity.

Levofloxacin may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Rash: mild skin erythema or itching. - Elevated liver enzymes: transient laboratory changes.

Serious or Rare Side Effects: - Tendon rupture: sudden pain or loss of function, especially in the Achilles tendon. - QT interval prolongation: risk of cardiac arrhythmias. - Clostridioides difficile infection: severe colitis with watery diarrhea. - Severe allergic reaction: anaphylaxis, angioedema, or Stevens‑Johnson syndrome. - Hepatic dysfunction: jaundice or marked liver enzyme elevation. - Central nervous system effects: seizures or severe confusion.

Levofloxacin should be used with caution in specific clinical situations. - Assess renal function: adjust therapy in patients with impaired clearance. - Monitor for tendon pain: discontinue if signs of tendonitis or rupture appear. - Avoid in known fluoroquinolone hypersensitivity: discontinue at first sign of allergy. - Use cautiously in patients with QT prolongation risk: review concomitant QT‑prolonging drugs. - Limit use with corticosteroids: increased risk of tendon injury. - Store at below 25°C: keep in the original container, protect from moisture and light.

Levofloxacin can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: markedly reduce levofloxacin absorption. - Warfarin: may potentiate anticoagulant effect and increase bleeding risk. - Theophylline: can raise serum theophylline concentrations, leading to toxicity. - Cyclosporine: increased cyclosporine levels may cause nephrotoxicity. - NSAIDs: combined use raises the chance of central nervous system stimulation.

Moderate Interactions (Monitor Closely): - Other fluoroquinolones (e.g., ciprofloxacin): additive QT‑prolongation potential. - Diabetes medications: may alter glycemic control, requiring closer monitoring. - Corticosteroids: concurrent use heightens tendon rupture risk.